Close Menu
Home » BGI Sequencer, Coronavirus Molecular Assays Granted Emergency Use Approval in China

BGI Sequencer, Coronavirus Molecular Assays Granted Emergency Use Approval in China

Jan 29, 2020
|
staff reporter

NEW YORK – BGI and its subsidiary MGI Tech said this week that their ultra-high-throughput sequencer DNBSEQ-T7, a metagenomic sequencing kit for coronaviruses, and 2019 novel coronavirus (2019-nCoV) reverse transcription PCR kit have all received emergency use approval from China's National Medical Products Administration.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The Scan

Cost of a Visa

The Guardian reports that visa costs could prevent scientists and others from coming to the UK.

Rethinking Access Order

The Trump Administration is reconsidering its plan to issue an executive order to require federally funded research to be freely available upon publication, Times Higher Education reports.

May Have to Close

Nature News says some preprint repositories may close down due to a lack of funds to cover costs.

Nature Papers Present Way to Analyze Cancer Mutational Signatures, Explore Treatment Resistance in Lung Cancer, More

In Nature this week: framework for analyzing cancer mutational signatures, treatment resistance in small cell lung cancer followed by increased intratumoral heterogeneity, and more.

What's Popular?

In Regulatory News & FDA Approvals

  1. Novacyt Gets CE Mark for Coronavirus Test

  2. FDA Releases List of Evidence-Based PGx Variants

  3. Yourgene Health Gets Australian Approval for Chemotoxicity Assay

Sponsorships

Privacy Policy.  Terms & Conditions.  .  Copyright © 2020 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.